Literature DB >> 7457531

Progesterone-induced smooth muscle-like cells in the subperitoneal nodules produced by estrogen. Experimental approach to leiomyomatosis peritonealis disseminata.

S Fujii, N Nakashima, H Okamura, A Takenaka, H Kanzaki, Y Okuda, K Morimoto, T Nishimura.   

Abstract

In order to examine the pathogenesis and histogenesis of leiomyomatosis peritonealis disseminata (LPD), guinea pigs were treated with various doses of estradiol benzoate (E) (40, 80, 100, and 200 microgram/day, three times a week, by intramuscular injection). After treatment for 3 months, each dose of E produced lesions simulating the disseminated pattern of LPD. Ultrastructurally, the nodules were considered to be composed of cells resembling those of fibroblast. In guinea pigs, pretreatment with estradiol benzoate (100 microgram/day, three times a week intramuscularly for 3 months followed by combination treatment with E and progesterone (P) (0.5 and 1.0 mg/day, once a week, intramuscularly) for 1 to 3 months produced nodules similar to those with estrogen alone. Ultrastructurally, these nodules were composed of cells resembling smooth muscle and decidual cells. According to these results, we conjectured that estrogen differentiates and proliferates cells with the features of fibroblast-like cells from the subcoelomic totipotential mesenchyme, and these cells are differentiated into smooth muscle-like cells and decidua-like cells under the influence of both estrogen and progesterone, resulting in the production of multiple subperitoneal nodules.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7457531     DOI: 10.1016/0002-9378(81)90440-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  11 in total

1.  Smooth muscle differentiation at endometrio-myometrial junction. An ultrastructural study.

Authors:  S Fujii; I Konishi; T Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

2.  Disseminated peritoneal leiomyomatosis. Clonality analysis by X chromosome inactivation and cytogenetics of a clinically benign smooth muscle proliferation.

Authors:  B J Quade; C M McLachlin; V Soto-Wright; J Zuckerman; G L Mutter; C C Morton
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

3.  Differentiation of smooth muscle in the genital tract of the female mouse and its temporal relation with the development of the Wolffian nerve.

Authors:  M M Brauer; M Pássaro; G Casanova; G Abeledo; P Barreiro
Journal:  Anat Embryol (Berl)       Date:  1989

4.  Leiomyomatosis peritonealis disseminata occurring in a postmenopausal woman: report of a case.

Authors:  M Komatsu; S Tsuchiya; T Kuroda
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

5.  Development of smooth muscle in the human fetal uterus: an ultrastructural study.

Authors:  I Konishi; S Fujii; H Okamura; T Mori
Journal:  J Anat       Date:  1984-09       Impact factor: 2.610

6.  Malignant neoplasms of decidual origin (deciduosarcomas) induced by estrogen-progestin-releasing intravaginal devices in rabbits.

Authors:  B C Zook; I Spiro; R Hertz
Journal:  Am J Pathol       Date:  1987-08       Impact factor: 4.307

7.  A case of angioleiomyoma in the buccal space.

Authors:  Tomohiro Inaba; Masatoshi Adachi; Hisao Yagisita
Journal:  Odontology       Date:  2013-08-02       Impact factor: 2.634

8.  Leiomyomatosis peritonealis disseminata in a Nigerian woman.

Authors:  Cyril C Dim; Sunday P Akogu; Hyginus U Ezegwui; Daniel B Olusina
Journal:  Niger Med J       Date:  2012-07

Review 9.  Familial clustering of Leiomyomatosis peritonealis disseminata: an unknown genetic syndrome?

Authors:  Niels Halama; Silke A Grauling-Halama; Isam Daboul
Journal:  BMC Gastroenterol       Date:  2005-10-13       Impact factor: 3.067

10.  Treatment of leiomyomatosis peritonealis disseminata with goserelin acetate: A case report and review of the literature.

Authors:  Jia-Wen Yang; Yu Hua; Hua Xu; Liu He; Hai-Zhong Huo; Chen-Fang Zhu
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.